Alignment Healthcare (NASDAQ:ALHC) Insider Sells $507,708.99 in Stock

Key Points

• Alignment Healthcare insider Christopher Joyce sold 30,939 shares for a total of $507,708.99, reducing his ownership by 8.26%.
• The company's stock price is currently at $16.45, with analysts providing a consensus rating of Moderate Buy and an average target price of $18.83.
• For the last quarter, Alignment Healthcare reported a revenue of $1.02 billion, exceeding analyst estimates and marking a 49% increase year-over-year.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Christopher Joyce sold 30,939 shares of the company's stock in a transaction that occurred on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $507,708.99. Following the completion of the sale, the insider owned 343,592 shares of the company's stock, valued at $5,638,344.72. This trade represents a 8.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Alignment Healthcare Stock Down 0.2%

Shares of ALHC stock traded down $0.03 during mid-day trading on Wednesday, hitting $16.45. 4,860,124 shares of the stock traded hands, compared to its average volume of 2,946,361. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29. The company's 50-day simple moving average is $14.27 and its 200-day simple moving average is $15.47. Alignment Healthcare, Inc. has a twelve month low of $8.82 and a twelve month high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. During the same period in the previous year, the company earned ($0.13) earnings per share. Alignment Healthcare's revenue was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Institutional Investors Weigh In On Alignment Healthcare

Several hedge funds have recently modified their holdings of the business. Amalgamated Bank increased its position in Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock worth $65,000 after acquiring an additional 616 shares during the period. Tidal Investments LLC grew its position in Alignment Healthcare by 4.9% in the 2nd quarter. Tidal Investments LLC now owns 18,094 shares of the company's stock worth $253,000 after purchasing an additional 852 shares during the last quarter. Ballentine Partners LLC increased its holdings in shares of Alignment Healthcare by 8.6% during the 1st quarter. Ballentine Partners LLC now owns 11,674 shares of the company's stock worth $217,000 after purchasing an additional 924 shares during the period. MCF Advisors LLC raised its position in shares of Alignment Healthcare by 87.6% during the first quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock valued at $40,000 after buying an additional 1,011 shares during the last quarter. Finally, Cresset Asset Management LLC lifted its stake in shares of Alignment Healthcare by 0.6% in the first quarter. Cresset Asset Management LLC now owns 287,565 shares of the company's stock valued at $5,354,000 after buying an additional 1,797 shares during the period. 86.19% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several brokerages recently commented on ALHC. KeyCorp upgraded shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target for the company in a research report on Monday, August 25th. Zacks Research raised Alignment Healthcare to a "hold" rating in a research report on Friday, August 8th. Wall Street Zen lowered Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, August 10th. Barclays raised Alignment Healthcare from an "underweight" rating to an "equal weight" rating and increased their price objective for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Finally, Stephens raised Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $18.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.